Gemcitabine in Recurrent Ovarian Cancer: A Viewpoint by M. Faruk Kose

By Kose M. Faruk  

American Journal of Cancer, Vol. 4, Iss. 5, 2005-01 ,pp. : 345-346

Adis International

Access to resources Recommend Favorite

Phase Ib Study of Drozitumab Combined With First-Line mFOLFOX6 Plus Bevacizumab in Patients with Metastatic Colorectal Cancer

By Rocha Lima Caio M.   Bayraktar Soley   Flores Aurea M.   MacIntyre Jessica   Montero Alberto   Baranda Joaquina C.   Wallmark John   Portera Chia   Raja Rajiv   Stern Howard   Royer-Joo Stephanie   Amler Lukas C.  

Cancer Investigation, Vol. 30, Iss. 10, 2012-12 ,pp. : 727-731

Informa Healthcare

Access to resources Recommend Favorite

Bevacizumab (Avastin®)

By Shimoyama Tatsu  

Japanese Journal of Cancer and Chemotherapy, Vol. 36, Iss. 3, 2009-03 ,pp. : 523-530

Sunmedia

Access to resources Recommend Favorite

Nasal septum perforation and bevacizumab

By Power Derek  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 89-93

Humana Press, Inc

Access to resources Recommend Favorite

Bevacizumab: In the Treatment of Colorectal Cancer

By Croom Katherine F.   Foster Rachel H.  

American Journal of Cancer, Vol. 3, Iss. 3, 2004-01 ,pp. : 187-194

Adis International

Access to resources Recommend Favorite